middle.news
Patrys Takes Intravenous Quetiapine Into Human Testing
8:57am on Wednesday 23rd of September, 2026 AEST
•
Biotechnology and Pharmaceuticals
Read Story
Patrys Takes Intravenous Quetiapine Into Human Testing
8:57am on Wednesday 23rd of September, 2026 AEST
Key Points
First participants dosed in RLS-2202 Phase 1a trial
Study will assess safety, tolerability and pharmacokinetics
RLS-2202 targets delirium treatment in acute-care settings
Cohort 2 material manufactured and undergoing quality testing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Patrys (ASX:PAB)
OPEN ARTICLE